FDA Grants HelixBind Breakthrough Device Designation for RaPID Sepsis Test
August 24, 2020 11:47 ET
|
HelixBind
BOXBOROUGH, Mass., Aug. 24, 2020 (GLOBE NEWSWIRE) -- HelixBind, which is developing an innovative diagnostic platform to revolutionize care for invasive infections such as sepsis, announced today it...
HelixBind Awarded $3MM Grant from NIH and Expands Clinical Advisory Board to Accelerate Development of Its Diagnostic Platform for Invasive Infections
June 10, 2020 10:29 ET
|
HelixBind
BOXBOROUGH, Mass., June 10, 2020 (GLOBE NEWSWIRE) -- HelixBind, which is developing an innovative diagnostic platform to revolutionize care for invasive infections such as sepsis, announced today it...
Arch Biopartners Expands Dosing in Phase I Trial for Metablok to Increase Dose Range for Future Phase II Studies
March 04, 2020 09:56 ET
|
Arch Biopartners
TORONTO, March 04, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that it is expanding the dose range of Metablok...
UPMC receives $3.7 million PCORI award to improve care for patients with sepsis and pneumonia
February 19, 2020 08:00 ET
|
UPMC Health Plan
Pittsburgh, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Today the UPMC Center for High-Value Health Care, a nonprofit research organization housed within UPMC Insurance Services, announced it has been...
Accelerate Diagnostics to Review Second Quarter 2018 Results on August 6th
July 19, 2018 14:30 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., July 19, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Monday, August 6, 2018 to review the company’s second quarter 2018...
Accelerate Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
June 05, 2018 11:30 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., June 05, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer is scheduled to speak at the William Blair...
Accelerate Diagnostics reports Q1 2018 financial results
May 09, 2018 16:03 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., May 09, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced financial results for the quarter ending March 31, 2018. The company generated revenue of $801,000, up...
Accelerate Diagnostics to Review First Quarter 2018 Results on May 9th
April 30, 2018 10:42 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., April 30, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 9, 2018 to review its first quarter 2018 financial...
Accelerate Diagnostics announces sizeable release of new data at ECCMID 2018
April 21, 2018 03:37 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., April 21, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the sizeable release of new data presented by the company, its customers, and clinical experts during...
Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017
February 15, 2018 16:05 ET
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary full-year 2017 financial results including the quarter ending December 31, 2017. The company...